|
"Mechanisms of Damage-Induced Homologous Recombination"
|
5R01CA079827-07
|
$240,641
|
$240,641
|
ENGELWARD, BEVIN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
2009 Calcium Signaling Gordon Research Conference
|
1R13CA147843-01
|
$3,000
|
$990
|
FOSKETT, KEVIN
|
GORDON RESEARCH CONFERENCES
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-02
|
$393,213
|
$98,303
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A new curcumin analogue with potent suppressive activity in pancreatic cancer
|
1R03CA137479-01A1
|
$76,320
|
$76,320
|
LIN, JIAYUH
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
A primary human xenograft model of pancreatic cancer.
|
1R03CA141245-01
|
$75,750
|
$75,750
|
BAUER, TODD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$1,031
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$900
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$65,940
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$525,807
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
1R21CA129302-01A2
|
$191,676
|
$191,676
|
Altomare, Deborah
|
FOX CHASE CANCER CENTER
|
|
Allergies and pancreatic cancer: A pooled analysis in PANC4
|
1R03CA141570-01
|
$94,800
|
$94,800
|
OLSON, SARA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
|
1R01CA129967-01A2
|
$307,100
|
$307,100
|
MITCHELL, ROBERT
|
UNIVERSITY OF LOUISVILLE
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-03
|
$429,479
|
$42,948
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
Anaerobic Bacteria as Oncopathic Agents for Pancreatic Cancer
|
1R01CA130897-01A2
|
$351,713
|
$351,713
|
Woo, Savio
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Analysis of Patient Tumor Responses to Apo2L/TRAIL
|
5R01CA108888-04
|
$305,795
|
$152,898
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-07
|
$344,459
|
$68,892
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Animal model of Pancreatic Cancer
|
ZIA BC 011186
|
$187,124
|
$187,124
|
Hussain, S. Perwez
|
CCR (NCI)
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$487,301
|
$24,365
|
Ho, Mitchell
|
CCR (NCI)
|
|
Are shared controls useful in genome-wide association studies for cancer genetic
|
1R03CA141524-01
|
$94,800
|
$94,800
|
Klein, Robert
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$542,939
|
$162,882
|
Avital, Itzhak
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$80,419
|
Albanes
|
DCEG (NCI)
|
|
ATDC Function in Human Pancreatic Adenocarcinoma
|
5R01CA131045-02
|
$318,258
|
$318,258
|
SIMEONE, DIANE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer
|
5R01CA095031-08
|
$314,790
|
$314,790
|
VON HOFF, DANIEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer
|
5U01CA128437-03
|
$279,165
|
$111,666
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
|
5R01CA132734-02
|
$313,533
|
$156,767
|
Vile, Richard
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
B7-H3 in prognosis and immunotherapy of pancreatic cancer
|
1R03CA141086-01
|
$101,423
|
$101,423
|
Wang, Xinhui
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$7,037
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$14,736
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$90,900
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$36,405
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical and Molecular Studies on DT Diaphorase
|
5R01CA051210-19
|
$323,691
|
$323,691
|
ROSS, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
|
Biological activity of ras oncogenes
|
5R01CA042978-23
|
$319,853
|
$319,853
|
DER, CHANNING
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
|
1U01CA141468-01
|
$482,978
|
$482,978
|
ENGLEMAN, EDGAR
|
STANFORD UNIVERSITY
|
|
Biomarker Reference Laboratory, EDRN
|
5U24CA086359-10
|
$446,996
|
$44,700
|
GRIZZLE, WILLIAM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Biomarkers and Therapeutic Targets in Pancreatic Cancer
|
5R01CA114103-05
|
$287,037
|
$287,037
|
WHANG, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biomarkers for the Early Detection of Pancreatic Cancer
|
3U01CA111302-05S1
|
$453,348
|
$453,348
|
KILLARY, ANN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$108,588
|
$21,718
|
Avital, Itzhak
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
$65,681
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer and Inflammation - Genetics and Function
|
ZIA BC 005652
|
$517,266
|
$51,727
|
Dean, Michael
|
CCR (NCI)
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
$999
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support
|
3P30CA047904-21S2
|
$5,021,590
|
$150,648
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-38
|
$2,844,058
|
$113,762
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S1
|
$113,210
|
$5,661
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S2
|
$124,410
|
$6,221
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S3
|
$99,940
|
$4,997
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-34
|
$10,451,830
|
$522,592
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
$39,998
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Pancreas for this search: $89,726,841
|